PDF (485K)
摘要
新生儿狼疮(NLE)是一种罕见的自身免疫性疾病,由母体自身抗体通过胎盘转运至胎儿循环系统所致,可能影响多个器官。抗 SSA/Ro、抗 SSB/La 和抗 U1RNP 抗体与 NLE 的发生关系最为密切,这些母体自身抗体可引发炎症反应,导致一系列临床表现,其中以先天性心脏传导阻滞(CHB)最为严重。并非所有接触母体自身抗体的胎儿/新生儿都会发生 NLE,提示该病的发生可能还与其他因素有关,包括遗传因素、Ⅰ型干扰素(IFN)、唾液酸结合免疫球蛋白样凝集素 1(SIGLEC-1)阳性巨噬细胞和孕期用药(羟氯喹、类固醇激素)等。一个或多个影响因素可能会改变 NLE 的发生风险,研究这些影响因素对降低 NLE 的发病率及死亡率有一定的临床指导作用。
Abstract
Neonatal lupus erythematosus (NLE) is a rare autoimmune disease, which is caused by the transfer of maternal autoantibodies through placenta to fetal circulatory system and may affect multiple organs. Anti- SSA/Ro, anti- SSB/La and anti- U1RNP antibodies are most closely related to NLE. These autoantibodies can trigger inflammatory reactions and lead to a series of clinical manifestations, among which congenital heart block (CHB) is the most serious. Not all fetuses/newborns exposed to maternal autoantibodies will develop NLE, suggesting that the occurrence of NLE may be associated with other factors, including genetic factors, type Ⅰ interferon, sialic acid bound Ig like lectin 1 (SIGLEC-1) positive macrophages, and medication (hydroxychloroquine, steroid hormones) used during pregnancy, etc. One or more factors may change the risk of NLE and have certain guiding roles in reducing the morbidity and mortality of NLE.
关键词
Key words
[Author(id=1329765373655191789, tenantId=1045748351789510663, journalId=1155139928303341746, articleId=1329765371943915673, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=2503689683@qq.com, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329765373709717745, tenantId=1045748351789510663, journalId=1155139928303341746, articleId=1329765371943915673, authorId=1329765373655191789, language=EN, stringName=Renhui CHEN, firstName=Renhui, middleName=null, lastName=CHEN, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=Department of Neonatology the First Affiliated Hospital of Dalian Medical University, Dalian 116011, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329765373755855091, tenantId=1045748351789510663, journalId=1155139928303341746, articleId=1329765371943915673, authorId=1329765373655191789, language=CN, stringName=陈仁慧, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=大连医科大学附属第一医院 新生儿科 ,辽宁 大连 116011, bio={"content":"陈仁慧(1992-),女,主治医师。E-mail: 2503689683@qq.com
"}, bioImg=null, bioContent=陈仁慧(1992-),女,主治医师。E-mail: 2503689683@qq.com
, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329765373588082919, tenantId=1045748351789510663, journalId=1155139928303341746, articleId=1329765371943915673, xref=null, ext=[AuthorCompanyExt(id=1329765373600665833, tenantId=1045748351789510663, journalId=1155139928303341746, articleId=1329765371943915673, companyId=1329765373588082919, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Department of Neonatology the First Affiliated Hospital of Dalian Medical University, Dalian 116011, China), AuthorCompanyExt(id=1329765373613248746, tenantId=1045748351789510663, journalId=1155139928303341746, articleId=1329765371943915673, companyId=1329765373588082919, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=大连医科大学附属第一医院 新生儿科 ,辽宁 大连 116011)])]), Author(id=1329765373801992438, tenantId=1045748351789510663, journalId=1155139928303341746, articleId=1329765371943915673, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=jihongsdq@126.com, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1329765373856518394, tenantId=1045748351789510663, journalId=1155139928303341746, articleId=1329765371943915673, authorId=1329765373801992438, language=EN, stringName=Hong JI, firstName=Hong, middleName=null, lastName=JI, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=Department of Neonatology the First Affiliated Hospital of Dalian Medical University, Dalian 116011, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329765373898461436, tenantId=1045748351789510663, journalId=1155139928303341746, articleId=1329765371943915673, authorId=1329765373801992438, language=CN, stringName=冀红, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=大连医科大学附属第一医院 新生儿科 ,辽宁 大连 116011, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329765373588082919, tenantId=1045748351789510663, journalId=1155139928303341746, articleId=1329765371943915673, xref=null, ext=[AuthorCompanyExt(id=1329765373600665833, tenantId=1045748351789510663, journalId=1155139928303341746, articleId=1329765371943915673, companyId=1329765373588082919, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Department of Neonatology the First Affiliated Hospital of Dalian Medical University, Dalian 116011, China), AuthorCompanyExt(id=1329765373613248746, tenantId=1045748351789510663, journalId=1155139928303341746, articleId=1329765371943915673, companyId=1329765373588082919, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=大连医科大学附属第一医院 新生儿科 ,辽宁 大连 116011)])])]
陈仁慧,冀红.
母体自身抗体及其他产前因素对新生儿狼疮预测价值的研究进展[J].
大连医科大学学报, 2026, 48(3): 275-279 DOI:10.11724/jdmu.2026.03.13
| [1] |
Derdulska JM, Rudnicka L, Szykut-Badaczewska A, et al. Neonatal lupus erythematosus-practical guidelines[J]. J Perinat Med, 2021, 49(5): 529-538. DOI: 10.1515/jpm-2020-0543.
|
| [2] |
Sun WQ, Fu CC, Jin XY, et al. Neonatal lupus erythematosus: an acquired autoimmune disease to be taken seriously[J]. Ann Med, 2025, 57(1): 2476049. DOI: 10.1080/07853890.2025.2476049.
|
| [3] |
Anuwutnavin S, Chuenchitkultavorn V, Nitiyarom R, et al. Prenatal predisposing factors associated with neonatal lupus erythematosus[J]. Lupus, 2022, 31(1): 77-88. DOI: 10.1177/09612033211066455.
|
| [4] |
Wang YA, Sibbald C, Moon AT. Retrospective, single-center case series of neonatal lupus[J]. Pediatr Dermatol, 2020, 37(3): 484-489. DOI: 10.1111/pde.14132.
|
| [5] |
Diaz T, Dominguez D, Jaeggi E, et al. Ethnicity and neonatal lupus erythematosus manifestations risk in a large multiethnic cohort[J]. J Rheumatol, 2021, 48(9): 1417-1421. DOI: 10.3899/jrheum.201338.
|
| [6] |
Gryka-Marton M, Szukiewicz D, Teliga-Czajkowska J, et al. An overview of neonatal lupus with anti-ro characteristics[J]. Int J Mol Sci, 2021, 22(17): 9281. DOI: 10.3390/ijms22179281.
|
| [7] |
Hansahiranwadee W. Diagnosis and management of fetal autoimmune atrioventricular block[J]. Int J Women's Health, 2020, 12: 633-639. DOI: 10.2147/IJWH.S257407.
|
| [8] |
Yang XF. Clinical features, autoantibodies, and outcome of neonatal lupus erythematosus[J]. Fetal Pediatr Pathol, 2022, 41(3): 436-442. DOI: 10.1080/15513815.2020.1836097.
|
| [9] |
Jaeggi E, Kulasingam V, Chen J, et al. Maternal anti-ro antibody titers obtained with commercially available immunoassays are strongly associated with immune-mediated fetal heart disease[J]. Arthritis Rheumatol, 2023, 75(9): 1556-1565. DOI: 10.1002/art.42513.
|
| [10] |
Buyon JP, Masson M, Izmirly CG, et al. Prospective evaluation of high titer autoantibodies and fetal home monitoring in the detection of atrioventricular block among anti-SSA/ro pregnancies[J]. Arthritis Rheumatol, 2024, 76(3): 411-420. DOI: 10.1002/art.42733.
|
| [11] |
De Carolis S, Garufi C, Garufi E, et al. Autoimmune congenital heart block: a review of biomarkers and management of pregnancy[J]. Front Pediatr, 2020, 8: 607515. DOI: 10.3389/fped.2020.607515.
|
| [12] |
Di Ludovico A, Rinaldi M, Mainieri F, et al. Molecular mechanisms of fetal and neonatal lupus: a narrative review of an autoimmune disease transferal across the placenta[J]. Int J Mol Sci, 2024, 25(10): 5224. DOI: 10.3390/ijms25105224.
|
| [13] |
Winikajtis-Burzyńska A, Brzosko M, Przepiera-Będzak H. Increased serum interleukin 10 levels are associated with increased disease activity and increased risk of anti-SS-A/ro antibody positivity in patients with systemic lupus erythematosus[J]. Biomolecules, 2023, 13(6): 974. DOI: 10.3390/biom13060974.
|
| [14] |
Fredi M, Argolini LM, Angeli F, et al. Anti-SSA/Ro positivity and congenital heart block: obstetric and foetal outcome in a cohort of anti-SSA/Ro positive pregnant patients with and without autoimmune diseases[J]. Clin Exp Rheumatol, 2022, 41(3): 685-693. DOI: 10.55563/clinexprheumatol/2ju0yv.
|
| [15] |
Wainwright B, Bhan R, Trad C, et al. Autoimmune-mediated congenital heart block[J]. Best Pract Res Clin Obstet Gynaecol, 2020, 64: 41-51. DOI: 10.1016/j.bpobgyn.2019.09.001.
|
| [16] |
Huang Y, Deng JL, Liu JH, et al. Autoimmune congenital heart block: a case report and review of the literature related to pathogenesis and pregnancy management[J]. Arthritis Res Ther, 2024, 26(1): 8. DOI: 10.1186/s13075-023-03246-w.
|
| [17] |
Matucci-Cerinic C, Viglizzo G, Ravelli A, et al. Neonatal lupus erythematosus in dizygotic twins with anti-RNP antibodies[J]. Clin Exp Rheumatol, 2021, 39(6): 1446. DOI: 10.55563/clinexprheumatol/88qnuv.
|
| [18] |
Radin M, Schreiber K, Cuadrado MJ, et al. Pregnancy outcomes in mixed connective tissue disease: a multicentre study[J]. Rheumatology, 2019, 58(11): 2000-2008. DOI: 10.1093/rheumatology/kez141.
|
| [19] |
Alfalasi M, ElGhazali G, Fathalla W, et al. Anti-U1RNP-70kD-positive case of neonatal lupus presenting with seizure and incomplete heart block: a case report and literature review[J]. Front Pediatr, 2023, 11: 1239327. DOI: 10.3389/fped.2023.1239327.
|
| [20] |
Bankole A, Nwaonu J. A review of neonatal lupus syndrome[J]. Sci Prog, 2024, 107(3): 00368504241278476. DOI: 10.1177/00368504241278476.
|
| [21] |
Meisgen S, Hedlund M, Ambrosi A, et al. Auxilin is a novel susceptibility gene for congenital heart block which directly impacts fetal heart function[J]. Ann Rheum Dis, 2022, 81(8): 1151-1161. DOI: 10.1136/annrheumdis-2021-221714.
|
| [22] |
Misztal MC, Gold N, Cao JJ, et al. Genetics of neonatal lupus erythematosus risk and specific manifestations[J]. J Rheumatol, 2025, 52(1): 52-57. DOI: 10.3899/jrheum.2023-1036.
|
| [23] |
Clancy RM, Halushka M, Rasmussen SE, et al. Siglec-1 macrophages and the contribution of IFN to the development of autoimmune congenital heart block[J]. J Immunol, 2019, 202(1): 48-55. DOI: 10.4049/jimmunol.1800357.
|
| [24] |
Hedlund M, Thorlacius GE, Ivanchenko M, et al. Type Ⅰ IFN system activation in newborns exposed to Ro/SSA and La/SSB autoantibodies in utero [J]. RMD Open, 2020, 6(1): e000989. DOI: 10.1136/rmdopen-2019-000989.
|
| [25] |
Sammaritano LR, Bermas BL, Chakravarty EE, et al. 2020 American college of rheumatology guideline for the management of reproductive health in rheumatic and musculoskeletal diseases[J]. Arthritis Rheumatol, 2020, 72(4): 529-556. DOI: 10.1002/art.41191.
|
| [26] |
Gamba A, Zen M, Depascale R, et al. Modern management of pregnancy in systemic lupus erythematosus: from prenatal counseling to postpartum support[J]. J Clin Med, 2024, 13(12): 3454. DOI: 10.3390/jcm13123454.
|
| [27] |
Izmirly P, Kim M, Friedman DM, et al. Hydroxychloroquine to prevent recurrent congenital heart block in fetuses of anti-SSA/ro-positive mothers[J]. J Am Coll Cardiol, 2020, 76(3): 292-302. DOI: 10.1016/j.jacc.2020.05.045.
|
| [28] |
Barsalou J, Costedoat-Chalumeau N, Berhanu A, et al. Effect of in utero hydroxychloroquine exposure on the development of cutaneous neonatal lupus erythematosus [J]. Ann Rheum Dis, 2018, 77(12): 1742-1749. DOI: 10.1136/annrheumdis-2018-213718.
|
| [29] |
Sonesson SE, Ambrosi A, Wahren-Herlenius M. Benefits of fetal echocardiographic surveillance in pregnancies at risk of congenital heart block: single-center study of 212 anti-Ro52-positive pregnancies[J]. Ultrasound Obstet Gynecol, 2019, 54(1): 87-95. DOI: 10.1002/uog.20214.
|
| [30] |
Michael A, Radwan AA, Ali AK, et al. Use of antenatal fluorinated corticosteroids in management of congenital heart block: systematic review and meta-analysis[J]. Eur J Obstet Gynecol Reprod Biol X, 2019, 4: 100072. DOI: 10.1016/j.eurox.2019.100072.
|
| [31] |
Nagliya D, Castellano C, Demory ML, et al. Sjogren's antibodies and neonatal lupus: a scoping review[J]. Cureus, 2024, 16(6): e62528. DOI: 10.7759/cureus.62528.
|
| [32] |
Patton KA, Siddique F, Lal AK. Systemic lupus and other autoimmune disorders during pregnancy[J]. Obstet Gynecol Clin North Am, 2025, 52(3): 581-597. DOI: 10.1016/j.ogc.2025.05.007.
|
| [33] |
Carlucci PM, Masson M, Cuneo BF, et al. Blocking the neonatal Fc receptor as a novel approach to prevent cardiac neonatal lupus: a proof-of-concept study[J]. Ann Rheum Dis, 2026, 85(1): 164-171. DOI: 10.1016/j.ard.2025.09.011.
|
| [34] |
Fu CC, Sun WQ, Peng HH, et al. Neonatal lupus erythematosus as a rare trigger of gastrointestinal involvement in neonates[J]. Sci Rep, 2024, 14: 3791. DOI: 10.1038/s41598-024-54091-z.
|